We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
-17.25%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$864M
AUM Growth
-$522M
(-38%)
Cap. Flow
-$225M
Cap. Flow
% of AUM
-26.07%
Top 10 Holdings %
Top 10 Hldgs %
51.12%
Holding
45
New
11
Increased
3
Reduced
14
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MGM Resorts International
MGM
|
+$42.6M |
| 2 |
UnitedHealth
UNH
|
+$40.6M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$37.9M |
| 4 |
Incyte
INCY
|
+$32.2M |
| 5 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$88.2M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$46.3M |
| 3 |
Humana
HUM
|
+$45.6M |
| 4 |
Heron Therapeutics
HRTX
|
+$40.5M |
| 5 |
LivaNova
LIVN
|
+$38.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 48.52% |
| 2 | Technology | 15.17% |
| 3 | Consumer Discretionary | 13.66% |
| 4 | Communication Services | 5.97% |
| 5 | Consumer Staples | 5.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Teva Pharmaceuticals
TEVA
$40.9B
| $13.5M | 1.56% |
1,500,000
| – | – |
|
27
Liberty Broadband Class A
LBRDA
$4.9B
| $9.4M | 1.09% |
87,833
| – | – |
|
28
TG Therapeutics
TGTX
$8B
| $8.35M | 0.97% |
848,221
-1,059,271
| -56% | -$13.4M |
|
|
PVG
29
DELISTED
PRETIUM RESOURCES INC.
PVG
| $7.97M | 0.92% |
1,406,412
| – | – |
|
|
ARNA
30
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $7.63M | 0.88% |
+181,786
| New | +$8.33M |
|
31
DexCom
DXCM
$32.1B
| $6.24M | 0.72% |
92,732
-50,468
| -35% | -$3.14M |
|
|
CZR
32
DELISTED
Caesars Entertainment Corporation
CZR
| $6.01M | 0.7% |
+889,497
| New | +$10.5M |
|
33
Quanterix
QTRX
$164M
| $5.58M | 0.65% |
+303,703
| New | +$6.93M |
|
34
CALL
Caesars Entertainment
CZR
$6.06B
| $3.6M | 0.42% |
+250,000
| New | +$11.7M |
|
35
Liberty Media Series C
FWONK
$24.6B
| $3.17M | 0.37% |
+120,433
| New | +$4.62M |
|
36
BellRing Brands
BRBR
$1.47B
| $1.71M | 0.2% |
100,000
| – | – |
|
37
AtriCure
ATRC
$1.93B
| – | – |
-261,524
| Closed | -$8.5M |
|
|
38
Heron Therapeutics
HRTX
$94.2M
| – | – |
-1,721,816
| Closed | -$40.5M |
|
|
39
Humana
HUM
$44.1B
| – | – |
-124,387
| Closed | -$45.6M |
|
|
40
LivaNova
LIVN
$4.42B
| – | – |
-507,621
| Closed | -$38.3M |
|
41
Madison Square Garden
MSGS
$9.57B
| – | – |
-62,787
| Closed | -$13.2M |
|
42
QuidelOrtho
QDEL
$1.13B
| – | – |
-286,697
| Closed | -$21.5M |
|
|
43
Zimmer Biomet
ZBH
$18.1B
| – | – |
-606,982
| Closed | -$88.2M |
|
|
MDCO
44
DELISTED
Medicines Co
MDCO
| – | – |
-305,002
| Closed | -$25.9M |
|
|
ZGNX
45
DELISTED
Zogenix, Inc.
ZGNX
| – | – |
-887,459
| Closed | -$46.3M |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q1 2020 Portfolio in Review
As of Q1 2020, Bridger Management held 45 positions worth $864M, down 38% from $1.39B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Bridger Management withdrew a net $225M in Q1 2020, closing 9 positions and reducing 14 holdings. Its most notable exit was Zimmer Biomet, an estimated $88.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 51% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Bridger Management opened a new position in UnitedHealth worth $36.8M.
- Bridger Management's largest Q1 2020 buy was UnitedHealth: 147,384 shares worth $36.8M.
- Bridger Management added most to MGM Resorts International in Q1 2020, an estimated $42.6M increase.
- Bridger Management's biggest Q1 2020 reduction was Alcon, cutting an estimated $31.8M.
- Bridger Management fully exited Zimmer Biomet in Q1 2020, selling an estimated $88.2M.
- Bridger Management's ten largest holdings make up 51% of its $864M portfolio in Q1 2020.
- Bridger Management opened 11 new positions and closed 9 in Q1 2020.
- Bridger Management's portfolio value fell 38% quarter-over-quarter to $864M.
Based on Bridger Management's 13F filing for Q1 2020, filed 15 May 2020.